A novel induced pluripotent stem cell model of schwann cell differentiation reveals NF2-related gene regulatory networks of the extracellular matrix

Olivia Lazaro,Sihong Li,William Carter,Oluwamayowa Awosika,Sylvia Robertson,Brooke E Hickey,Steven P Angus,Austin House,D. Wade Clapp,Abdul S Qadir,Travis S Johnson,Steven D Rhodes

DOI: https://doi.org/10.1101/2024.05.02.591952

2024-07-03

Abstract:Schwann cells are vital to development and maintenance of the peripheral nervous system and their dysfunction has been implicated in a range of neurological and neoplastic disorders, including NF2-related schwannomatosis. We developed a novel human induced pluripotent stem cell (hiPSC) model to study Schwann cell differentiation in health and disease. We performed transcriptomic, immunofluorescence, and morphological analysis of hiPSC derived Schwann cell precursors (SPCs) and terminally differentiated Schwann cells (SCs) representing distinct stages of development. To validate our findings, we performed integrated, cross-species analyses across multiple external datasets at bulk and single cell resolution. Our hiPSC model of Schwann cell development shared overlapping gene expression signatures with human amniotic mesenchymal stem cell (hAMSCs) derived SCs and in vivo mouse models, but also revealed unique features that may reflect species-specific aspects of Schwann cell biology. Moreover, we identified gene co-expression modules that are dynamically regulated during hiPSC to SC differentiation associated with ear and neural development, cell fate determination, the NF2 gene, and extracellular matrix (ECM) organization. By cross-referencing results between multiple datasets, we identified new genes potentially associated with NF2 expression. Our hiPSC model further provides a tractable platform for studying Schwann cell development in the context of human disease.

Bioinformatics

What problem does this paper attempt to address?

The problem this paper attempts to address is: by developing a novel human induced pluripotent stem cell (hiPSC) model to study the differentiation process of Schwann cells (SCs), it aims to reveal the gene regulatory network of the extracellular matrix (ECM) associated with the NF2 gene. Specifically, the paper aims to:

1. **Establish a reliable hiPSC model**: for studying Schwann cell differentiation in both healthy and disease states.
2. **Analyze gene expression changes**: by using transcriptomics, immunofluorescence, and morphological analysis to study the gene expression characteristics of Schwann cell precursors (SPCs) and terminally differentiated Schwann cells at different stages of differentiation.
3. **Validate the model's effectiveness**: by conducting comprehensive analyses across species and multiple datasets to verify the reliability and specificity of the hiPSC model.
4. **Identify key gene modules**: using systems biology methods such as weighted gene co-expression network analysis (WGCNA) to identify gene modules dynamically regulated during Schwann cell differentiation, particularly those related to the NF2 gene and extracellular matrix organization.
5. **Discover new gene associations**: by comparing results across multiple datasets to identify new genes that may be associated with NF2 gene expression.

Through these studies, the authors hope to provide new insights into the molecular mechanisms of Schwann cell development and NF2-related diseases, and to offer potential targets for future therapeutic strategies.